Article in Journal of natural products, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 5 institutions in 3 countries.
Mirta ResetarDepartment of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.ORCID 0000-0002-1432-8731
Borris R Tietcheu GalaniDepartment of Biological Sciences, Faculty of Science, University of Ngaoundere, PO Box 454, Ngaoundere, Adamawa, Cameroon.
Armelle T TsamoDepartment of Organic Chemistry, Faculty of Science, University of Yaounde I, PO Box 812, Yaounde, Cameroon.
Ya ChenDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
Daniel SchachnerDepartment of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.
Stefanie StolzlechnerCenter for Cancer Research, Medical University of Vienna, Borschkegasse 8a, 1090 Vienna, Austria.
Julio I Mawouma PagnaDepartment of Organic Chemistry, Faculty of Science, University of Yaounde I, PO Box 812, Yaounde, Cameroon.
Mehdi A BeniddirÉquipe "Chimie des Substances Naturelles" BioCIS, CNRS, Université Paris-Saclay, 17 Avenue des Sciences, 91400 Orsay, France.ORCID 0000-0003-2153-4290
Johannes KirchmairDepartment of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.ORCID 0000-0003-2667-5877
Verena M DirschDepartment of Pharmaceutical Sciences, Division of Pharmacognosy, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.ORCID 0000-0002-9261-5293
University of Vienna · ATUniversité de Yaoundé I · CMCentre National de la Recherche Scientifique · FRMedical University of Vienna · ATUniversity of Ngaoundéré · CM
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
In this study, the ability of six limonoids from
Indexed as
LimoninsMeliaceaeCholesterolLiver X ReceptorsOrphan Nuclear ReceptorsCholesterolflindissoneLimoninsLiver X ReceptorsOrphan Nuclear Receptors
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.